Oncoinvent has dosed the first subject in the Phase II clinical trial of Radspherin, an alpha-radiation therapy, for the treatment of peritoneal carcinomatosis originating from ovarian cancer. The ...

Ovarian cancer is considered to be the most serious of women's cancers. That's why experts say women should know about their risks and prevention.

Some doctors believe a minor gynecological procedure called an opportunistic salpingectomy can dramatically reduce the risk of ovarian cancer. Originally published on June 17, 2023.

A pairing of two experimental drugs inhibits tumor growth and blocks drug-induced resistance in ovarian cancer, according to a preclinical study led by Weill Cornell Medicine investigators.

A widower has said his wife received a late and terminal diagnosis due to an ongoing lack of awareness about symptoms of ovarian cancer among health professionals. Stephen McCormick, whose wife ...

There’s no way to screen for so-called ovarian cancer, no colonoscopy, mammogram, or Pap smear equivalent. It’s typically found late, once it’s already spread.

"Today’s approval of AVMAPKI FAKZYNJA CO-PACK for patients with KRAS-mutated recurrent low-grade serous ovarian cancer represents not only the first-ever FDA-approved treatment specifically for ...

Lilly presents first clinical data for its investigational, next-generation FRα targeting ADC in platinum-resistant ovarian cancer at the 2025 ASCO Annual Meeting Lilly presents first clinical ...